Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07349134 · ClinicalTrials.gov registry record · NA

WELL-MPN: A Digital Lifestyle App for Patients With MPNs

A NA study, sponsored by Brigham and Women's Hospital.

Not yet
Registry status
NA
Development phase
75
Enrollment target

NCT07349134 is a NA study that has not yet begun recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 75 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07349134, a NA study, has not yet begun recruiting, sponsored by Brigham and Women's Hospital.

NOT YET RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target

Study Summary

The goal of this clinical trial is to learn whether a digital lifestyle app can help improve diet, physical activity, symptoms, emotional well-being, and quality of life in adults with myeloproliferative neoplasms (MPNs). The main questions it aims to answer are: Can people with MPNs use the WELL-MPN app? Does using the WELL-MPN app improve diet quality and physical activity? Does the WELL-MPN app improve MPN-related symptoms, anxiety and depression, confidence in managing health, and overall quality of life? Researchers will compare participants who use the WELL-MPN digital app with participants who receive written educational materials about diet and physical activity for people with cancer to see if the app leads to greater improvements in lifestyle behaviors, symptoms, and well-being. Participants will: Be randomly assigned to use the WELL-MPN app or receive written lifestyle education materials Use the assigned program or materials over the study period Complete surveys about diet, physical activity, symptoms, mood, confidence in self-care, and quality of life

Interventions

  • BEHAVIORAL WELL-MPN Digital App

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2026-06
Est. Completion 2029-06
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT07349134

The ClinicalTrials.gov registry entry for NCT07349134 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which WELL-MPN Digital App is the first listed.

NCT07349134 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07349134 about?

NCT07349134 is a clinical study titled "WELL-MPN: A Digital Lifestyle App for Patients With MPNs". The goal of this clinical trial is to learn whether a digital lifestyle app can help improve diet, physical activity, symptoms, emotional well-being, and quality of life in adults with myeloproliferative neoplasms (MPNs). The main questions it aims to answer are: Can people with MPNs use the WELL-...

What is the current status of trial NCT07349134?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2026-06. Estimated completion is 2029-06.

What interventions are being tested in trial NCT07349134?

The interventions under investigation include: WELL-MPN Digital App (BEHAVIORAL).

Who is sponsoring clinical trial NCT07349134?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.